Related Experiment Video

Updated: Aug 6, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.1K

eIF4F translation initiation complex, a predictive marker of response to immunotherapy in mucosal melanoma

Antoine Moya-Plana1, Carine Ngo2, Emilie Lanoy3

  • 1Head & Neck Surgery Department, Gustave Roussy Cancer Campus, Villejuif, France; Inserm U981, Melanoma Group, Gustave Roussy Cancer Campus, Villejuif, France.

European Journal of Cancer (Oxford, England : 1990)
|March 14, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.7K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Related Experiment Videos

Last Updated: Aug 6, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.1K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.7K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K

Articles linked to this work by shared authors, journal, and citation graph.

HMGA2::NCOR2 fusion-driven giant cell tumors: Diagnosis and treatment.

Critical reviews in oncology/hematology·2026

Reconstruction of the Skull Base Using Temporalis Fascia after Endoscopic Resection of Advanced Nasal Sinus Cancer: A Step-by-step Video.

Journal of neurological surgery. Part B, Skull base·2026

Quality of surgical reporting and adequacy of surgical treatment in salivary gland cancer: a quality assurance ancillary study of the GORTEC 2016-02 SANTAL trial.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026

European Standard Clinical Practice Recommendations for Olfactory Neuroblastoma in Children and Adolescents: An Updated Consensus by the Expert Group.

Pediatric blood & cancer·2026

Dedifferentiated Chondrosarcoma: Current Advances and Future Perspectives.

Current treatment options in oncology·2026

Economic evaluation of adjuvant chemotherapy for non-metastatic sarcoma using the real-world data from the French nationwide DEEPSARC study.

Journal of medical economics·2026

Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.

European journal of cancer (Oxford, England : 1990)·2026

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.

European journal of cancer (Oxford, England : 1990)·2026

Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.

European journal of cancer (Oxford, England : 1990)·2026

Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.

European journal of cancer (Oxford, England : 1990)·2026

Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.

European journal of cancer (Oxford, England : 1990)·2026

Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.

European journal of cancer (Oxford, England : 1990)·2026

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

Cureus·2026

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

ACS central science·2026

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Frontiers in immunology·2026

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

Frontiers in oncology·2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

BMC medicine·2026

Imaging features of soft tissue hibernoma: a review of 73 cases.

Skeletal radiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us